HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Full Thickness Macular Hole Formation in a Patient with Cystoid Macular Edema Caused by CRVO Treated with Intravitreal Bevacizicumab.

Abstract
Recent studies have shown the beneficial effect of intravitreal injections of Bevacizicumab in several ocular neovasular disorders, however, the possible adverse effects of this treatment have not been fully described. The authors report the development of a full thickness macular hole (FTMH) in a 44-year-old patient with cystoid macular edema secondary to central retinal vein occlusion after treatment with intravitreal injection of Bevacizicumab and describe its course after vitrectomy, internal limiting membrane peeling and gas tamponade.
AuthorsIlias Georgalas, Alexandros Rouvas, Athanasios Kotsolis, Dimitrios Karagiannis, Ioannis Ladas
JournalOphthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye (Ophthalmic Surg Lasers Imaging) Pg. 1-4 (Mar 09 2010) ISSN: 1938-2375 [Electronic] United States
PMID20337340 (Publication Type: Journal Article)
CopyrightCopyright 2010, SLACK Incorporated.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: